Moderna Begins COVID Vaccine Study for Children

The first group of children have been vaccinated in Moderna’s latest phase of a pediatric Covid-19 vaccine trial. The trial called the ‘KidCOVE’ study will monitor 6,750 children in the U.S. and Canada between the ages of 6 months and 11 years old. It’s broken into two parts, in the first, different doses of the same vaccine are being tested on children. Those between 6 months and 1 year will receive two doses of the vaccine spaced 28 days apart at either 25, 50, or 100 micrograms levels. Children between 2 and 11 will receive 2 doses in either 50 or 100 micrograms.
In the second part, the trial will include children who are given a placebo that does nothing and they’ll be followed for 12 months after their 2nd injection. The study is a collaboration with the National Institute of Allergy and Infectious Diseases at the National Institutes of Health and the Biomedical Advanced Research and Development Authority at the U.S. Department of Health and Human Services. Speaking of children, a mother in Florida gave birth to the first-known baby with Covid-19 antibodies. She was 36 weeks pregnant when she received her first dose of the Moderna vaccine and received her second dose during the postpartum period.